Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Clear Cell Renal Cell Carcinoma Metastatic|TNBC - Triple-Negative Breast Cancer|Head and Neck Cancer|Non-small-cell Lung Carcinoma|Mesothelioma, Malignant
Interventions: DRUG: CA9hu-1
Sponsor: Mabpro, a.s.